Latest Action: 06/10/2008 - Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S5455-5456)

Bill Text
A concurrent resolution expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.

6/10/2008--Introduced.

Calls for the Food and Drug Administration (FDA) to reverse its policy that aims to eliminate patient access to compounded medications containing estriol prescribed by physicians unless it holds a public comment period on the issue and can document evidence of adverse events and other safety issues to justify such policy.

Latest Action: 05/07/2008 - Referred to the Subcommittee on Health.

Bill Text
Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.

5/6/2008--Introduced.

Calls for the Food and Drug Administration (FDA) to reverse its policy that aims to eliminate patient access to compounded medications containing estriol prescribed by physicians.

Latest Action: 09/11/2007 - Referred to the Subcommittee on Health, Employment, Labor, and Pensions.

Bill Text
To amend the Public Health Service Act and Employee Retirement Income Security Act of 1974 to require that group and individual health insurance coverage and group health plans provide coverage for qualified individuals for bone mass measurement (bone density testing) to prevent fractures associated with osteoporosis. 6/28/2007--Introduced. Osteoporosis Early Detection and Prevention Act of 2007 - Amends the Public Health Service Act and the Employee Retirement Income Security Act of 1974 (ERISA) to require a group health plan to include coverage for bone mass measurement for individuals who: (1) are at a clinical risk for osteoporosis, including estrogen-deficient women; (2) have vertebral abnormalities; (3) are receiving chemotherapy or long-term gluococorticoid (steroid) therapy; (4) have primary hyperparathyroidism, hyperthyroidism, or excess thyroid replacement; or (5) are being monitored to assess the response to or efficacy of approved osteoporosis drug therapy. Requires [...]

show full description
Latest Action: 05/25/2007 - Referred to the Subcommittee on Health.

Bill Text
To amend title XVIII of the Social Security Act to expand coverage of bone mass measurements under part B of the Medicare Program to all individuals at clinical risk for osteoporosis.

5/16/2007--Introduced.

Medicare Osteoporosis Measurement Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act to provide for coverage of bone mass measurements for all individuals at clinical risk for osteoporosis.

Latest Action: 07/09/2007 - Referred to the Subcommittee on Health, Employment, Labor, and Pensions.

Bill Text
To provide for coverage of hormone replacement therapy for treatment of menopausal symptoms, and for coverage of an alternative therapy for hormone replacement therapy for such symptoms, under the Medicare and Medicaid Programs, group health plans and individual health insurance coverage, and other Federal health insurance programs. 3/29/2007--Introduced. .Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act of 2007 - Amends the Social Security Act to include coverage of hormone replacement therapy for menopausal symptoms and alternative treatments for such therapy under Medicare (title XVIII of the Act). Includes alternative treatments for hormone replacement therapy for menopausal symptoms under Medicaid (title XIX of the Act).Requires coverage of hormone replacement therapy for menopausal symptoms and alternative treatments for such therapy on the same basis as outpatient prescription drugs under: (1) the Public Health Service Act [...]

show full description